Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study.

Sujenthiran A, Parry M, Nossiter J, Berry B, Cathcart PJ, Clarke NW, Payne H, van der Meulen J, Aggarwal A.

Clin Oncol (R Coll Radiol). 2020 Mar 3. pii: S0936-6555(20)30044-3. doi: 10.1016/j.clon.2020.02.004. [Epub ahead of print]

PMID:
32143901
2.

Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study.

Berry B, Parry MG, Sujenthiran A, Nossiter J, Cowling TE, Aggarwal A, Cathcart P, Payne H, van der Meulen J, Clarke N.

BJU Int. 2020 Mar 2. doi: 10.1111/bju.15039. [Epub ahead of print]

PMID:
32124525
3.

Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial.

Scarsbrook AF, Bottomley D, Teoh EJ, Bradley KM, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Han S, Leung HY, Chau A, Miller MP, Gleeson FV; FALCON study group.

Int J Radiat Oncol Biol Phys. 2020 Feb 14. pii: S0360-3016(20)30203-0. doi: 10.1016/j.ijrobp.2020.01.050. [Epub ahead of print]

4.

Single-Centre Experience of the Use of Palliative Radiotherapy in Metastatic Castrate-Resistant Prostate Cancer between 2003/2004 and 2018/2019.

Kinnaird W, Davda R, Payne H.

Clin Oncol (R Coll Radiol). 2020 Feb 6. pii: S0936-6555(20)30035-2. doi: 10.1016/j.clon.2020.01.027. [Epub ahead of print] No abstract available.

PMID:
32037184
5.

Autophagy regulates functional differentiation of mammary epithelial cells.

Elswood J, Pearson SJ, Payne HR, Barhoumi R, Rijnkels M, W Porter W.

Autophagy. 2020 Feb 5:1-19. doi: 10.1080/15548627.2020.1720427. [Epub ahead of print]

PMID:
31983267
6.

Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England.

Nossiter J, Sujenthiran A, Cowling TE, Parry MG, Charman SC, Cathcart P, Clarke NW, Payne H, van der Meulen J, Aggarwal A.

J Clin Oncol. 2020 Mar 1;38(7):744-752. doi: 10.1200/JCO.19.01538. Epub 2020 Jan 2.

PMID:
31895608
7.

Medically Unexplained Symptoms and Attachment Theory: The BodyMind Approach®.

Payne H, Brooks SD.

Front Psychol. 2019 Nov 6;10:1818. doi: 10.3389/fpsyg.2019.01818. eCollection 2019.

8.

Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.

Adeleke S, Latifoltojar A, Sidhu H, Galazi M, Shah TT, Clemente J, Davda R, Payne HA, Chouhan MD, Lioumi M, Chua S, Freeman A, Rodriguez-Justo M, Coolen A, Vadgama S, Morris S, Cook GJ, Bomanji J, Arya M, Chowdhury S, Wan S, Haroon A, Ng T, Ahmed HU, Punwani S.

BMC Med Imaging. 2019 Nov 15;19(1):90. doi: 10.1186/s12880-019-0380-y.

9.

Identifying skeletal-related events for prostate cancer patients in routinely collected hospital data.

Parry MG, Cowling TE, Sujenthiran A, Nossiter J, Berry B, Cathcart P, Clarke NW, Payne H, Aggarwal A, van der Meulen J.

Cancer Epidemiol. 2019 Dec;63:101628. doi: 10.1016/j.canep.2019.101628. Epub 2019 Nov 9.

PMID:
31715436
10.

Expanding the Role of Pharmacists in HIV Prevention.

Payne HE.

Am J Public Health. 2019 Nov;109(11):e21. doi: 10.2105/AJPH.2019.305321. No abstract available.

PMID:
31577507
11.

Patients' and partners' views of care and treatment provided for metastatic castrate-resistant prostate cancer in the UK.

Catt S, Matthews L, May S, Payne H, Mason M, Jenkins V.

Eur J Cancer Care (Engl). 2019 Nov;28(6):e13140. doi: 10.1111/ecc.13140. Epub 2019 Sep 1.

PMID:
31475410
12.

Appropriation of GPIbα from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation.

Chimen M, Evryviadou A, Box CL, Harrison MJ, Hazeldine J, Dib LH, Kuravi SJ, Payne H, Price JMJ, Kavanagh D, Iqbal AJ, Lax S, Kalia N, Brill A, Thomas SG, Belli A, Crombie N, Adams RA, Evans SA, Deckmyn H, Lord JM, Harrison P, Watson SP, Nash GB, Rainger GE.

Haematologica. 2019 Aug 29. pii: haematol.2018.215145. doi: 10.3324/haematol.2018.215145. [Epub ahead of print]

13.
14.

Re: David W. Donnelly, Anna Gavin, Amy Downing, et al. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom. Eur Urol 2019;76:228-37.

Clarke N, Payne H, van der Meulen J.

Eur Urol. 2020 Mar;77(3):e65. doi: 10.1016/j.eururo.2019.06.001. Epub 2019 Jun 15. No abstract available.

PMID:
31213325
15.

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients.

Boyle HJ, Alibhai S, Decoster L, Efstathiou E, Fizazi K, Mottet N, Oudard S, Payne H, Prentice M, Puts M, Aapro M, Droz JP.

Eur J Cancer. 2019 Jul;116:116-136. doi: 10.1016/j.ejca.2019.04.031. Epub 2019 Jun 10. Review.

PMID:
31195356
16.

Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based Study.

Parry MG, Sujenthiran A, Cowling TE, Nossiter J, Cathcart P, Clarke NW, Payne H, van der Meulen J, Aggarwal A.

J Clin Oncol. 2019 Jul 20;37(21):1828-1835. doi: 10.1200/JCO.18.02237. Epub 2019 Jun 4.

PMID:
31163009
17.

Cerebellar Purkinje cells control eye movements with a rapid rate code that is invariant to spike irregularity.

Payne HL, French RL, Guo CC, Nguyen-Vu TB, Manninen T, Raymond JL.

Elife. 2019 May 3;8. pii: e37102. doi: 10.7554/eLife.37102.

18.

Cerebral lateralisation during signed and spoken language production in children born deaf.

Payne H, Gutierrez-Sigut E, Woll B, MacSweeney M.

Dev Cogn Neurosci. 2019 Apr;36:100619. doi: 10.1016/j.dcn.2019.100619. Epub 2019 Jan 24.

19.

Tspan18 is a novel regulator of the Ca2+ channel Orai1 and von Willebrand factor release in endothelial cells.

Noy PJ, Gavin RL, Colombo D, Haining EJ, Reyat JS, Payne H, Thielmann I, Lokman AB, Neag G, Yang J, Lloyd T, Harrison N, Heath VL, Gardiner C, Whitworth KM, Robinson J, Koo CZ, Di Maio A, Harrison P, Lee SP, Michelangeli F, Kalia N, Rainger GE, Nieswandt B, Brill A, Watson SP, Tomlinson MG.

Haematologica. 2019 Sep;104(9):1892-1905. doi: 10.3324/haematol.2018.194241. Epub 2018 Dec 20.

20.

Evaluation of stakeholder views on peer review of NIHR applications for funding: a qualitative study.

Turner S, Bull A, Chinnery F, Hinks J, Mcardle N, Moran R, Payne H, Woodford Guegan E, Worswick L, Wyatt JC.

BMJ Open. 2018 Dec 14;8(12):e022548. doi: 10.1136/bmjopen-2018-022548.

21.

Influence of external peer reviewer scores for funding applications on funding board decisions: a retrospective analysis of 1561 reviews.

Sorrell L, Mcardle N, Becque T, Payne H, Stuart B, Turner S, Wyatt JC.

BMJ Open. 2018 Dec 14;8(12):e022547. doi: 10.1136/bmjopen-2018-022547.

22.

Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in England.

Parry MG, Sujenthiran A, Cowling TE, Nossiter J, Cathcart P, Clarke NW, Payne H, Aggarwal A, van der Meulen J.

Int J Cancer. 2019 Jul 1;145(1):40-48. doi: 10.1002/ijc.32068. Epub 2019 Jan 17.

23.
24.

Treatment Experiences, Information Needs, Pain and Quality of Life in Men with Metastatic Castrate-resistant Prostate Cancer: Results from the EXTREQOL Study.

Jenkins V, Solis-Trapala I, Payne H, Mason M, Fallowfield L, May S, Matthews L, Catt S.

Clin Oncol (R Coll Radiol). 2019 Feb;31(2):99-107. doi: 10.1016/j.clon.2018.11.001. Epub 2018 Nov 23.

PMID:
30473408
25.

Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions.

Parry MG, Sujenthiran A, Cowling TE, Charman S, Nossiter J, Aggarwal A, Clarke NW, Payne H, van der Meulen J.

Cancer Epidemiol. 2019 Feb;58:44-51. doi: 10.1016/j.canep.2018.11.003. Epub 2018 Nov 18.

PMID:
30463041
26.

Data on SD-OCT image acquisition, ultrastructural features, and horizontal tissue shrinkage in the porcine retina.

Xie W, Zhao M, Tsai SH, Burkes WL, Potts LB, Xu W, Payne HR, Hein TW, Kuo L, Rosa RH Jr.

Data Brief. 2018 Oct 27;21:1019-1025. doi: 10.1016/j.dib.2018.10.123. eCollection 2018 Dec.

27.

Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro-oncologists' opinions and practice.

Payne H, McMenemin R, Bahl A, Greene D, Staffurth J.

Int J Clin Pract. 2019 Sep;73(9):1-6. doi: 10.1111/ijcp.13292. Epub 2018 Dec 4.

PMID:
30414348
28.

Naive B Cell Output in HIV-Infected and HIV-Uninfected Children.

Payne H, Chain G, Adams S, Hunter P, Luckhurst N, Gilmour K, Lewis J, Babiker A, Cotton M, Violari A, Gibb D, Callard R, Klein N.

AIDS Res Hum Retroviruses. 2019 Jan;35(1):33-39. doi: 10.1089/AID.2018.0170. Epub 2018 Dec 26.

29.

RADICAL(S) Radiotherapy Post-prostatectomy, Current and Future Practice.

McGrane J, Mark F, Troup J, Parker C, Payne H.

Clin Oncol (R Coll Radiol). 2018 Dec;30(12):793-797. doi: 10.1016/j.clon.2018.08.014. Epub 2018 Sep 10. No abstract available.

PMID:
30213705
30.

Evaluation of density gradient ultracentrifugation serum lipoprotein profiles in healthy dogs and dogs with exocrine pancreatic insufficiency.

Minamoto T, Parambeth JC, Walzem RL, Payne HR, Lidbury JA, Suchodolski JS, Steiner JM.

J Vet Diagn Invest. 2018 Nov;30(6):878-886. doi: 10.1177/1040638718793677. Epub 2018 Sep 3.

31.

Preferences for Toxicity Monitoring of Patients on Abiraterone Acetate Plus Prednisone.

Payne H, Jamieson L, Prentice M, O'Connor A, Wong ICK, Chambers P.

Clin Oncol (R Coll Radiol). 2018 Oct;30(10):674-675. doi: 10.1016/j.clon.2018.07.023. Epub 2018 Aug 24. No abstract available.

PMID:
30149920
32.

Correlation of spectral domain optical coherence tomography with histology and electron microscopy in the porcine retina.

Xie W, Zhao M, Tsai SH, Burkes WL, Potts LB, Xu W, Payne HR, Hein TW, Kuo L, Rosa RH Jr.

Exp Eye Res. 2018 Dec;177:181-190. doi: 10.1016/j.exer.2018.08.003. Epub 2018 Aug 16.

33.

Altered lipoprotein profiles in cats with hepatic lipidosis.

Minamoto T, Walzem RL, Hamilton AJ, Hill SL, Payne HR, Lidbury JA, Suchodolski JS, Steiner JM.

J Feline Med Surg. 2019 Apr;21(4):363-372. doi: 10.1177/1098612X18780060. Epub 2018 Jun 4.

PMID:
29860906
34.

Exercise training as a novel primary treatment for localised prostate cancer: a multi-site randomised controlled phase II study.

Bourke L, Stevenson R, Turner R, Hooper R, Sasieni P, Greasley R, Morrissey D, Loosemore M, Fisher A, Payne H, Taylor SJC, Rosario DJ.

Sci Rep. 2018 May 30;8(1):8374. doi: 10.1038/s41598-018-26682-0.

35.

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study.

Sujenthiran A, Nossiter J, Parry M, Charman SC, Cathcart PJ, van der Meulen J, Clarke NW, Payne H, Aggarwal A.

Radiother Oncol. 2018 Aug;128(2):357-363. doi: 10.1016/j.radonc.2018.04.032. Epub 2018 May 14.

PMID:
29773442
36.

Hospital Choice in Cancer Care: A Qualitative Study.

Aggarwal A, Bernays S, Payne H, van der Meulen J, Davis C.

Clin Oncol (R Coll Radiol). 2018 Jul;30(7):e67-e73. doi: 10.1016/j.clon.2018.03.009. Epub 2018 Apr 19.

PMID:
29680734
37.

Experimental study of beam distortion due to fiducial markers during salvage HIFU in the prostate.

Bakaric M, Martin E, S Georgiou P, T Cox B, Payne H, E Treeby B.

J Ther Ultrasound. 2018 Mar 22;6:1. doi: 10.1186/s40349-018-0109-3. eCollection 2018.

38.

EXTREQOL Identifies Ongoing Challenges in Maximising Quality of Survival in Men with Metastatic Castrate-resistant Prostate Cancer.

Jenkins V, Payne H, Mason M, May S, Matthews L, Catt S.

Clin Oncol (R Coll Radiol). 2018 Jun;30(6):331-333. doi: 10.1016/j.clon.2018.02.001. Epub 2018 Feb 16. No abstract available.

PMID:
29459101
39.

Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018.

Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Teoh EJ, Bottomley D, Scarsbrook A, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Chau A, Ward P, Miller MP, Stevens DJ, Wilson L, Gleeson FV, Scheidhauer K, Seidl C, Autenrieth M, Bruchertseifer F, Apostolidis C, Kurtz F, Horn T, Pfob C, Schwaiger M, Gschwend J, D'Alessandria C, Morgenstern A, Uprimny C, Kroiss A, Decristoforo C, von Guggenberg E, Nilica B, Horninger W, Virgolini I, Rasul S, Poetsch N, Woehrer A, Preusser M, Mitterhauser M, Wadsak W, Widhalm G, Mischkulnig M, Hacker M, Traub-Weidinger T, Wright CL, Binzel K, Wuthrick EJ, Miller ED, Maniawski P, Zhang J, Knopp MV, Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L, Mairinger S, Filip T, Sauberer M, Flunkert S, Wanek T, Stanek J, Okamura N, Langer O, Kuntner C, Fornito MC, Balzano R, Di Martino V, Cacciaguerra S, Russo G, Seifert D, Kleinova M, Cepa A, Ralis J, Hanc P, Lebeda O, Mosa M, Vandenberghe S, Mikhaylova E, Borys D, Viswanath V, Stockhoff M, Efthimiou N, Caribe P, Van Holen R, Karp JS, Binzel K, Zhang J, Wright CL, Maniawski P, Knopp MV, Haller PM, Farhan C, Piackova E, Jäger B, Knoll P, Kiss A, Podesser BK, Wojta J, Huber K, Mirzaei S, Traxl A, Komposch K, Glitzner E, Wanek T, Mairinger S, Sibilia M, Langer O, Fornito MC, Russello M, Russo G, Balzano R, Sorko S, Gallowitsch HJ, Kohlfuerst S, Matschnig S, Rieser M, Sorschag M, Lind P, Ležaič L, Rep S, Žibert J, Frelih N, Šuštar S, Binzel K, Adelaja A, Wright CL, Scharre D, Zhang J, Knopp MV, Baum RP, Langbein T, Singh A, Shahinfar M, Schuchardt C, Volk GF, Kulkarni HR, Fornito MC, Cacciaguerra S, Balzano R, Di Martino GV, Russo G, Thomson WH, Kudlacek M, Karik M, Farhan C, Rieger H, Pokieser W, Glaser K, Mirzaei S, Petz V, Tugendsam C, Buchinger W, Schmoll-Hauer B, Schenk IP, Rudolph K, Krebs M, Zettinig G, Zoufal V, Wanek T, Krohn M, Mairinger S, Stanek J, Sauberer M, Filip T, Pahnke J, Langer O, Weitzer F, Pernthaler B, Salamon S, Aigner R, Koranda P, Henzlová L, Kamínek M, Váchalová M, Bachleda P, Summer D, Garousi J, Oroujeni M, Mitran B, Andersson KG, Vorobyeva A, Löfblom JN, Orlova A, Tolmachev V, Decristoforo C, Kaeopookum P, Summer D, Orasch T, Lechner B, Petrik M, Novy Z, Rangger C, Haas H, Decristoforo C.

EJNMMI Res. 2018 Jan 23;8(Suppl 1):5. doi: 10.1186/s13550-017-0354-4. No abstract available.

40.

Robot-assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England.

Nossiter J, Sujenthiran A, Charman SC, Cathcart PJ, Aggarwal A, Payne H, Clarke NW, van der Meulen J.

Br J Cancer. 2018 Feb 20;118(4):489-494. doi: 10.1038/bjc.2017.454. Epub 2018 Jan 18.

41.

Timing Rules for Synaptic Plasticity Matched to Behavioral Function.

Suvrathan A, Payne HL, Raymond JL.

Neuron. 2018 Jan 3;97(1):248-250. doi: 10.1016/j.neuron.2017.12.019. No abstract available.

42.

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis.

Payne H, Brill A.

J Vis Exp. 2017 Dec 22;(130). doi: 10.3791/56697.

43.

Toxicity Outcomes in the Elderly Prostate Cancer Patient.

Prentice M, Davda R, Nuhoglu Savas A, Payne H.

Clin Oncol (R Coll Radiol). 2018 Jan;30(1):e37. doi: 10.1016/j.clon.2017.10.018. Epub 2017 Nov 20. No abstract available.

PMID:
29157797
44.

National cohort study comparing severe medium-term urinary complications after robot-assisted vs laparoscopic vs retropubic open radical prostatectomy.

Sujenthiran A, Nossiter J, Parry M, Charman SC, Aggarwal A, Payne H, Dasgupta P, Clarke NW, van der Meulen J, Cathcart P.

BJU Int. 2018 Mar;121(3):445-452. doi: 10.1111/bju.14054. Epub 2017 Nov 15.

45.

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial.

Lewis J, Payne H, Walker AS, Otwombe K, Gibb DM, Babiker AG, Panchia R, Cotton MF, Violari A, Klein N, Callard RE.

Front Immunol. 2017 Sep 20;8:1162. doi: 10.3389/fimmu.2017.01162. eCollection 2017.

46.

National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.

Sujenthiran A, Nossiter J, Charman SC, Parry M, Dasgupta P, van der Meulen J, Cathcart PJ, Clarke NW, Payne H, Aggarwal A.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1253-1260. doi: 10.1016/j.ijrobp.2017.07.040. Epub 2017 Sep 1.

47.

Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study.

Aggarwal A, Lewis D, Sujenthiran A, Charman SC, Sullivan R, Payne H, Mason M, van der Meulen J.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1261-1270. doi: 10.1016/j.ijrobp.2017.08.018. Epub 2017 Aug 24.

48.

Magnetic eye tracking in mice.

Payne HL, Raymond JL.

Elife. 2017 Sep 5;6. pii: e29222. doi: 10.7554/eLife.29222.

49.

The Public Health Innovation Model: Merging Private Sector Processes with Public Health Strengths.

Lister C, Payne H, Hanson CL, Barnes MD, Davis SF, Manwaring T.

Front Public Health. 2017 Aug 7;5:192. doi: 10.3389/fpubh.2017.00192. eCollection 2017.

50.

What Box: A task for assessing language lateralization in young children.

Badcock NA, Spooner R, Hofmann J, Flitton A, Elliott S, Kurylowicz L, Lavrencic LM, Payne HM, Holt GK, Holden A, Churches OF, Kohler MJ, Keage HAD.

Laterality. 2018 Jul;23(4):391-408. doi: 10.1080/1357650X.2017.1363773. Epub 2017 Aug 13.

PMID:
28803507

Supplemental Content

Support Center